Market Value670,201,000
Total Holdings65
File Date2020-02-12
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
LJPC / La Jolla Pharmaceutical Co.
MGTX / MeiraGTx Holdings plc
US69354M1080 / PRA Health Sciences Inc
US0153511094 / Alexion Pharmaceuticals, Inc.
AGIO / Agios Pharmaceuticals, Inc.
XLRN / Acceleron Pharma Inc
CSII / Cardiovascular Systems Inc.
0PP / Portola Pharmaceuticals Inc
RARX / Ra Pharmaceuticals, Inc.
URGN / UroGen Pharma Ltd.
VCEL / Vericel Corporation
NXTC / NextCure, Inc.
OBSV / ObsEva SA.
VRAY / ViewRay Inc.
STML / Stemline Therapeutics, Inc.
AERI / Aerie Pharmaceuticals Inc
EVLO / Evelo Biosciences, Inc.
HRC / Hill-Rom Holdings Inc
VCRA / Vocera Communication Inc
TRHC / Tabula Rasa HealthCare Inc
COLL / Collegium Pharmaceutical, Inc.
MTEM / Molecular Templates, Inc.
/ Immunomedics, Inc.
GBT / Global Blood Therapeutics Inc.
US40425J1016 / HMS Holdings Corp.
NVS / Novartis AG - Depositary Receipt (Common Stock)
BPMC / Blueprint Medicines Corporation
98235T107 / Wright Medical Group N.V.
PHAS / PhaseBio Pharmaceuticals Inc
CHNG / Change Healthcare Inc
FGEN / FibroGen, Inc.
FSTX / F-star Therapeutics Inc
018490100 / Allergan plc
TDOC / Teladoc Health, Inc.
FTSV / Forty Seven, Inc.
FIXX / Homology Medicines, Inc.
APRE / Aprea Therapeutics, Inc.
ALBO / Albireo Pharma Inc
TFX / Teleflex Incorporated
IRTC / iRhythm Technologies, Inc.
SVRA / Savara Inc.
ASMB / Assembly Biosciences, Inc.
RCM / R1 RCM Inc.
SWAV / Shockwave Medical, Inc.
INSP / Inspire Medical Systems, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
SGEN / Seagen Inc
BMRN / BioMarin Pharmaceutical Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
TNDM / Tandem Diabetes Care, Inc.
SAGE / Sage Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
SILK / Silk Road Medical, Inc
ATRC / AtriCure, Inc.
PFE / Pfizer Inc.
FOLD / Amicus Therapeutics, Inc.
QURE / uniQure N.V.
MDT / Medtronic plc
ABT / Abbott Laboratories
ILMN / Illumina, Inc.
BSX / Boston Scientific Corporation
ALNY / Alnylam Pharmaceuticals, Inc.
ZBH / Zimmer Biomet Holdings, Inc.
MRK / Merck & Co., Inc.
BMY / Bristol-Myers Squibb Company
COGT / Cogent Biosciences, Inc.
SRPT / Sarepta Therapeutics, Inc.
CI / The Cigna Group
APLS / Apellis Pharmaceuticals, Inc.
BIIB / Biogen Inc.
EVH / Evolent Health, Inc.
UNH / UnitedHealth Group Incorporated
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
TMO / Thermo Fisher Scientific Inc.
LLY / Eli Lilly and Company
VRTX / Vertex Pharmaceuticals Incorporated
INCY / Incyte Corporation
AMGN / Amgen Inc.
PTCT / PTC Therapeutics, Inc.
GILD / Gilead Sciences, Inc.